The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
Open accessAbstract
We used mice deficient in each of the eight types and subtypes of prostanoid receptors and examined the roles of prostanoids in dextran sodium sulfate-induced (DSS-induced) colitis.Among the prostanoid receptor-deficient mice, only EP4-deficient mice and not mice deficient in either DP, EP1, EP2, EP3, FP, IP, or TP developed severe colitis with 3% DSS treatment, which induced only marginal colitis in wild-type mice.This phenotype was mimicked in wild-type mice by administration of an EP4-selective antagonist (AE3-208).The EP4 deficiency impaired mucosal barrier function and induced epithelial loss, crypt damage, and aggregation of neutrophils and lymphocytes in the colon.Conversely, administration of an EP4-selective agonist (AE1-734) to wild-type mice ameliorated severe colitis normally induced with 7% DSS, while that of AE3-208 suppressed recovery from colitis and induced significant proliferation of CD4 + T cells.In vitro AE3-208 enhanced and AE1-734 suppressed the proliferation and Th1 cytokine production of lamina propria mononuclear cells from the colon.DNA microarray analysis revealed elevated expression of genes associated with immune response and reduced expression of genes with mucosal repair and remodeling in the colon of EP4-deficient mice.We conclude that EP4 maintains intestinal homeostasis by keeping mucosal integrity and downregulating immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prostanoid Receptors: Structures, Properties, and Functions
Narumiya, S., Sugimoto, Y., & Ushikubi, F. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1193 · Cited by 2,412
Self-citationThe Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410
Inflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., & Seibert, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3228 · Cited by 1,310 · cited 1×
“This dose of indomethacin was reported to inhibit PGE2 production in rats and mice in vivo (22, 23).”
BackgroundExperimental models of inflammatory bowel disease
Elson, C. O., Sartor, R. B., Tennyson, G. S., & Riddell, R. H. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90599-5 · Cited by 1,212
Dieleman, L. A., Palmen, M. J. H. J., Akol, H., Bloemena, E., PEña, A. S., Meuwissen, S. G. M., & Van Rees, E. P. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1998.00728.x · Cited by 1,165
Powrie, F., Leach, M. W., Mauze, S., Menon, S., Barcomb Caddle, L., & Coffman, R. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90045-0 · Cited by 1,146 · cited 1×
“Unrestrained activation of CD4+ T cells (42) and an excessive production of IFN-γ produced by Th1 cells (43, 44) have been suggested as the factors in protraction of IBD.”
BackgroundBerg, D. J., Davidson, N., Kühn, R., Müller, W., Menon, S., Holland, G., Thompson-Snipes, L., Leach, M. W., & Rennick, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118861 · Cited by 1,136
Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans
Bjarnason, I., Hayllar, J., Macpherson, A. N. D. J., & Russell, A. N. T. S. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90667-2 · Cited by 1,022
Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773
Self-citationProstaglandin D 2 as a Mediator of Allergic Asthma
Matsuoka, T., Hirata, M., Tanaka, H., Takahashi, Y., Murata, T., Kabashima, K., Sugimoto, Y., Kobayashi, T., Ushikubi, F., Aze, Y., et al. (2000) · Science · doi:10.1126/science.287.5460.2013 · Cited by 743
Self-citationImpaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
Ushikubi, F., Segi, E., Sugimoto, Y., Murata, T., Matsuoka, T., Kobayashi, T., Hizaki, H., Tuboi, K., Katsuyama, M., Ichikawa, A., et al. (1998) · Nature · doi:10.1038/26233 · Cited by 677
Self-citationDextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice
Dieleman, L. A., Ridwan, B. U., Tennyson, G. S., Beagley, K. W., Bucy, R. P., & Elson, C. O. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90803-6 · Cited by 677
Failure of Parturition in Mice Lacking the Prostaglandin F Receptor
Sugimoto, Y., Yamasaki, A., Segi, E., Tsuboi, K., Aze, Y., Nishimura, T., Oida, H., Yoshida, N., Tanaka, T., Katsuyama, M., et al. (1997) · Science · doi:10.1126/science.277.5326.681 · Cited by 608
Self-citationHizaki, H., Segi, E., Sugimoto, Y., Hirose, M., Saji, T., Ushikubi, F., Matsuoka, T., Noda, Y., Tanaka, T., Yoshida, N., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10501 · Cited by 465
Self-citationCyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease
Singer, I. I., Kawka, D. W., Schloemann, S., Tessner, T., Riehl, T., & Stenson, W. F. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70196-9 · Cited by 455
Animal models of mucosal inflammation and their relation to human inflammatory bowel disease
Blumberg, R. S., Saubermann, L. J., & Strober, W. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00032-1 · Cited by 449
Reuter, B. K., Asfaha, S., Buret, A., Sharkey, K. A., & Wallace, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119013 · Cited by 423
Role of Prostaglandins in Ulcerative Colitis
Sharon, P., Ligumsky, M., Rachmilewitz, D., & Zor, U. (1978) · Gastroenterology · doi:10.1016/s0016-5085(19)31672-5 · Cited by 388
The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth
Nguyen, M., Camenisch, T., Snouwaert, J. N., Hicks, E., Coffman, T. M., Anderson, P. A. W., Malouf, N. N., & Koller, B. H. (1997) · Nature · doi:10.1038/36342 · Cited by 363
Nonsteroidal Anti-Inflammatory Drugs Activate Quiescent Inflammatory Bowel Disease
KAUFMANN, H. J., & TAUBIN, H. L. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-4-513 · Cited by 346
Patent Ductus Arteriosus and Neonatal Death in Prostaglandin Receptor EP4-Deficient Mice
Segi, E., Sugimoto, Y., Yamasaki, A., Aze, Y., Oida, H., Nishimura, T., Murata, T., Matsuoka, T., Ushikubi, F., Hirose, M., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8461 · Cited by 313
Self-citationEffects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study
Felder, J. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01054-6 · Cited by 290
Morteau, O., Morham, S. G., Sellon, R., Dieleman, L. A., Langenbach, R., Smithies, O., & Sartor, R. B. (2000) · Journal of Clinical Investigation · doi:10.1172/jci6899 · Cited by 275
Newberry, R. D., Stenson, W. F., & Lorenz, R. G. (1999) · Nature Medicine · doi:10.1038/11341 · Cited by 264
Cohn, S. M., Schloemann, S., Tessner, T., Seibert, K., & Stenson, W. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119296 · Cited by 224
Axelsson, L. G., Landström, E., Goldschmidt, T. J., Grönberg, A., & Bylund-Fellenius, A. C. (1996) · Inflammation Research · doi:10.1007/bf02285159 · Cited by 174
Shinomiya, S., Naraba, H., Ueno, A., Utsunomiya, I., Maruyama, T., Ohuchida, S., Ushikubi, F., Yuki, K., Narumiya, S., Sugimoto, Y., et al. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00586-x · Cited by 172
Self-citationKweon, M.-N., Yamamoto, M., Kajiki, M., Takahashi, I., & Kiyono, H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8490 · Cited by 163
Inflammatory bowel disease incidence: up, down or unchanged?
Logan, R. F. (1998) · Gut · doi:10.1136/gut.42.3.309 · Cited by 154
Tessner, T. G., Cohn, S. M., Schloemann, S. R., & Stenson, W. F. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70259-8 · Cited by 138
Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats
Fedorak, R. N., Empey, L. R., Macarthur, C., & Jewell, L. D. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90280-e · Cited by 128
Allgayer, H., DeSchryver, K., & Stenson, W. F. (1989) · Gastroenterology · doi:10.1016/s0016-5085(89)80016-2 · Cited by 123
Newberry, R. D., McDonough, J. S., Stenson, W. F., & Lorenz, R. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4465 · Cited by 110
Carty, E., Brabander, M. D., Feakins, R. M., & Rampton, D. S. (2000) · Gut · doi:10.1136/gut.46.4.487 · Cited by 99
Prostanoids in human colonic mucosa: effects of inflammation on PGE2 receptor expression
Cosme, R., Lublin, D., Takafuji, V., et al. (2000) · Human Immunology · doi:10.1016/s0198-8859(00)00131-2 · Cited by 52
Okada, Y., Hara, A., Ma, H., Xiao, C., Takahata, O., Kohgo, Y., Narumiya, S., & Ushikubi, F. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703627 · Cited by 49
Self-citationEicosanoids and the large intestine☆
Krause, W. F., & DuBois, R. N. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00069-1 · Cited by 43
Morteau, O. (1999) · Nature Medicine · doi:10.1038/11301 · Cited by 21
Cited by
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
Abraham, C., & Cho, J. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804647 · Cited by 2,712
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103
Kaser, A., Zeissig, S., & Blumberg, R. S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101225 · Cited by 1,806
A Randomized Trial of Aspirin to Prevent Colorectal Adenomas
Baron, J. A., Cole, B. F., Sandler, R. S., Haile, R. W., Ahnen, D., Bresalier, R., McKeown-Eyssen, G., Summers, R. W., Rothstein, R., Burke, C. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021735 · Cited by 1,416
Metadata
- Authors
- Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., Ichikawa, A., & Narumiya, S.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-04-01
- Volume
- 109
- Issue
- 7
- Pages
- 883-893
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4243630079
- Cited by
- 418
- References
- 39
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.